Onkologie. 2013:7(6):292-295

Mandibular angiosarcoma

Richard Pink1, Patrik Flodr2, Peter Tvrdý1, Jindřich Pazdera1
1 Klinika ústní, čelistní a obličejové chirurgie FN a LF UP Olomouc
2 Ústav patologie LF UP Olomouc

Introduction: Malignant mesenchymal tumours of the orofacial region are extremely rare and comprise only 1% of all malignant orofacial

tumours with more than 50 subtypes. Angiosarcomas are highly malignant neoplasms that originate from blood or lymphatic vessels.

Angiosarcomas form 5,4 % of all sarcomas and in the head and neck region are the most frequent type of sarcoma.

Aim: The aim of this case report is to describe a rare malignant neoplasm in the head and neck topography which can be diagnostic

difficulty and may be missed or unrecognised with fatal consequences for the patient.

Materials, methods, results: The authors describe the clinical manifestations of the disease, the diagnosis and therapy of mandibular

angiosarcoma in a seriously ill patient. The diagnosis was made on the basis of the histopathological findings and immunohistochemistry.

The following treatment was radical surgery with subsequent radiotherapy and 18 months later, the 84 year old female patient

remains alive and apparently healthy.

Conclusions: Angiosarcoma has currently been literary described only in small number of patients. Guidelines for optimal treatment

are still unknown and the average survival is one year and a half.

Keywords: mesenchymal tumours, angiosarcoma, orofacial tumours

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pink R, Flodr P, Tvrdý P, Pazdera J. Mandibular angiosarcoma. Onkologie. 2013;7(6):292-295.
Download citation

References

  1. Rossi S, Fletcher CD. Angiosarcoma arising in hemangioma/ vascular malformation: report of four cases and review of the literature. Am J Surg Pathol 2007; 26: 1319-1329. Go to original source... Go to PubMed...
  2. Stewart FW, Treves N. Lymphangioma in postmastectomy lymphedema: a report of six cases in elephantiasis chrurgica. Cancer 1948; 1: 64-81. Go to original source...
  3. Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristic, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer 2005; 11: 241-247. Go to original source... Go to PubMed...
  4. Huang J, Mackillop WJ. Increased risk og soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 2001; 92: 172-180. Go to original source...
  5. Karlsson P, Holmberk E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment for breast cancer - a Swedish population - based study. Eur J Cancer 1998; 34: 2068-2075. Go to original source... Go to PubMed...
  6. Bosetti C, La Vecchia C, Lipworth L, McLaughlin JK. Occupational exposure to vinyl chloridand cancer risk: a review of the epidemiologic literature. Eur J Cancer Prev 2003; 12: 427 - 30. Go to original source... Go to PubMed...
  7. Broders AC, Hargrave R, Meyerding HW. Pathological feathures of the soft tissue sarcoma: With specisl refence to the grading of its malignancy. Surg Gynecol Obstet 1939; 69: 267.
  8. Russell WO, Cohen J, Cutler S. Paging system fot soft tissue sarcoma. Task force on soft tissue sarcoma. American Joint Committie for cancer paging and end results reporting. Chicago: American College of surgeons. 1980.
  9. Banks-Davi H J, Haemorhagic angiosarcoma of upper jaw. Proc R Soc Med 1923; 16: 49. Go to original source...
  10. Ohsawa M, Naka N, Tomita Y, Kawamori D, Kanno H, Aozasa K. Use of imunohistochemical procedures in diagnosting angiosarcoma.: Evaluation of 98 cases. Canrer 1995; 75: 2867-2874. Go to original source... Go to PubMed...
  11. Pawlik TM, Paulino AF, McGinn CJ. Cutaneus angiosarcoma of the scalp: a multidisciplinary approach.: Cancer 2003; 98: 1716-1726. Go to original source... Go to PubMed...
  12. Fata F, O´Reilly E, Ilson D. Paclitaxel in the treatment of patients with angiosarcoma of the scalp of face. Cancer 1999; 86: 2034-2037. Go to original source...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.